uniQure (QURE) Cash from Financing Activities (2016 - 2026)
uniQure (QURE) posted Cash from Financing Activities of $249.1 million for Q2 2026, up 45193.82% on a QoQ basis from $550000.0 in Q1 2026, and up 566072.73% year-over-year from N/an in Q2 2025.
uniQure (QURE) Cash from Financing Activities (2016 - 2026) Analysis & Trends
uniQure has reported Cash from Financing Activities for 11 years, with the latest figure at $249.1 million in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 566072.73% year-over-year to $249.1 million in Q2 2026; TTM through Jun 2026 was $584.4 million, a 2659.23% increase from a year earlier, with the FY2025 full-year figure at $415.4 million, up 798.31% from the prior year.
- Cash from Financing Activities was $249.1 million for Q2 2026 at uniQure, up from $550000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $370.1 million in Q2 2023, with the low at -$53.0 million in Q3 2024.
- Average Cash from Financing Activities over 5 years is $60.6 million, with a median of $393000.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 638067.24% in 2023, then plunged 14267.39% in 2024.
- Over 5 years, Cash from Financing Activities stood at $601000.0 in 2022, then tumbled by 92.35% to $46000.0 in 2023, then slumped by 14267.39% to -$6.5 million in 2024, then soared by 137.58% to $2.4 million in 2025, then jumped by 10072.15% to $249.1 million in 2026.
- The last three Cash from Financing Activities figures came in at $249.1 million (Q2 2026), $550000.0 (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | -426.70 Mn |
| 10 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | 249.12 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 249.12 Mn |
| Mar 31, 2026 | 550,000.00 |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 332.24 Mn |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 80.67 Mn |
| Dec 31, 2024 | -6.52 Mn |
| Sep 30, 2024 | -53.02 Mn |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | -7.59 Mn |
| Jun 30, 2023 | 370.14 Mn |
| Mar 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 601,000.00 |
| Sep 30, 2022 | 301,000.00 |
| Jun 30, 2022 | 58,000.00 |
| Mar 31, 2022 | 485,000.00 |
| Dec 31, 2021 | 29.89 Mn |
| Sep 30, 2021 | -164,000.00 |
| Jun 30, 2021 | 2.51 Mn |
| Mar 31, 2021 | 62.62 Mn |
uniQure Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=QURE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "QURE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=QURE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();